121 related articles for article (PubMed ID: 19455018)
1. Rapidly worsening hypertriglyceridemia during treatment with risperidone.
Kohen I; Manu P
Am J Ther; 2010; 17(2):216-8. PubMed ID: 19455018
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
3. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
[TBL] [Abstract][Full Text] [Related]
4. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
5. Effects of atypical antipsychotics on weight and serum lipid levels.
Meyer JM
J Clin Psychiatry; 2001; 62 Suppl 27():27-34; discussion 40-1. PubMed ID: 11806486
[TBL] [Abstract][Full Text] [Related]
6. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
7. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-associated increase in triglyceride levels.
Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
[No Abstract] [Full Text] [Related]
9. Metabolic syndrome in female patients with schizophrenia treated with second generation antipsychotics: a 3-month follow-up.
Medved V; Kuzman MR; Jovanovic N; Grubisin J; Kuzman T
J Psychopharmacol; 2009 Nov; 23(8):915-22. PubMed ID: 18635691
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
11. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
12. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
13. Effects of obesity surgery on the metabolic syndrome.
Lee WJ; Huang MT; Wang W; Lin CM; Chen TC; Lai IR
Arch Surg; 2004 Oct; 139(10):1088-92. PubMed ID: 15492149
[TBL] [Abstract][Full Text] [Related]
14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
15. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
Faludi G
Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
[TBL] [Abstract][Full Text] [Related]
16. [Utilisation of atypical antipsychotic drugs in institutionalised elderly persons and prevalence of metabolic alterations].
Martínez Romero G; Peris Martí JF; Gomar Fayos J; Navarro Gosalbez M; Quintana Vargas I; Muelas Tirado J
Farm Hosp; 2010; 34(3):139-47. PubMed ID: 20434929
[TBL] [Abstract][Full Text] [Related]
17. [Hyperlipidemia--side-effect of the treatment with an atypical antipsychotic (zotepine)?].
Wetterling T
Psychiatr Prax; 2002 Nov; 29(8):438-40. PubMed ID: 12436365
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic-induced hyponatremia: case report and literature review.
Kohen I; Voelker S; Manu P
Am J Ther; 2008; 15(5):492-4. PubMed ID: 18806526
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
[TBL] [Abstract][Full Text] [Related]
20. Angioneurotic edema with risperidone: a case report and review of literature.
Soumya RN; Grover S; Dutt A; Gaur N
Gen Hosp Psychiatry; 2010; 32(6):646.e1-3. PubMed ID: 21112458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]